Literature DB >> 19696545

[Clinical characteristics and changing epidemiology of Clostridium difficile-associated disease (CDAD)].

Tae Jun Byun1, Dong Soo Han, Sang Bong Ahn, Hyun Seok Cho, Tae Yeob Kim, Chang Soo Eun, Yong Cheol Jeon, Joo Hyun Sohn, Jung Oak Kang.   

Abstract

BACKGROUND/AIMS: The spectrum of Clostridium difficile-associated disease (CDAD) ranges from mild diarrhea to life-threatening colitis. Recent studies reported an increase in incidence and severity of CDAD and the presence of severe community-acquired CDAD (CA-CDAD). The aims of this study were to investigate the incidence of CA-CDAD and non-antibiotics-associated CDAD, and to compare the clinical characteristics between hospital-acquired (HA) and CA-CDAD.
METHODS: The medical records of 86 patients who were diagnosed as CDAD in Hanyang University Guri Hospital between January 2005 and October 2007 were retrospectively reviewed.
RESULTS: Of the 86 patients (mean age 64 years), 53 patients were women. The most frequently prescribed antibiotics were cephalosporins (67.4%), followed by aminoglycosides (38.4%) and quinolones (14%). Of the 86 patients, the average duration of treatment and recovery time of symptoms were 11.5 days and 4.6 days, respectively. Seven percent of patients experienced relapse treatment. The overall incidence rate of CA-CDAD and non-antibiotics-associated CDAD were 10.5% and 22.1%, respectively. CA-CDAD group had lower rate of antimicrobial exposure whilst showing higher rate of complications compared to HA-CDAD group. Three patients in the CA-CDAD progressed towards a severe complicated clinical course, including septic shock.
CONCLUSIONS: The incidence rate of CA-CDAD and non-antibiotics-associated CDAD were 10.5% and 22.1%, respectively. CA-CDAD tends to have a higher complication rate compared to HA-CDAD. Community clinicians needs to maintain a high level of suspicion for CDAD, whilst coping with the ever evolving epidemiologic change.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19696545     DOI: 10.4166/kjg.2009.54.1.13

Source DB:  PubMed          Journal:  Korean J Gastroenterol        ISSN: 1598-9992


  6 in total

1.  Risk Factors for Treatment Failure and Recurrence after Metronidazole Treatment for Clostridium difficile-associated Diarrhea.

Authors:  Kyu Sik Jung; Jae Jun Park; Young Eun Chon; Eun Suk Jung; Hyun Jung Lee; Hui Won Jang; Kyong Joo Lee; Sang Hoon Lee; Chang Mo Moon; Jin Ha Lee; Jae Kook Shin; Soung Min Jeon; Sung Pil Hong; Tae Il Kim; Won Ho Kim; Jae Hee Cheon
Journal:  Gut Liver       Date:  2010-09-24       Impact factor: 4.519

2.  Characterization of cases of Clostridium difficile infection (CDI) presenting at an emergency room: molecular and clinical features differentiate community-onset hospital-associated and community-associated CDI in a tertiary care hospital.

Authors:  Bo-Moon Shin; Se Jin Moon; You Sun Kim; Won Chang Shin; Hyeon Mi Yoo
Journal:  J Clin Microbiol       Date:  2011-04-06       Impact factor: 5.948

3.  Incidence and clinical features of Clostridium difficile infection in Korea: a nationwide study.

Authors:  Y S Kim; D S Han; Y H Kim; W H Kim; J S Kim; H S Kim; H S Kim; Y S Park; H J Song; S J Shin; S K Yang; B D Ye; C S Eun; K M Lee; S H Lee; B I Jang; S A Jung; J H Cheon; C H Choi; K C Huh
Journal:  Epidemiol Infect       Date:  2012-04-12       Impact factor: 4.434

4.  Epidemiology and clinical characteristics of Clostridium difficile infection in a Korean tertiary hospital.

Authors:  Jieun Kim; Hyunjoo Pai; Mi-ran Seo; Jung Oak Kang
Journal:  J Korean Med Sci       Date:  2011-10-01       Impact factor: 2.153

5.  Risk factors for recurrence of Clostridium difficile infection: effect of vancomycin-resistant enterococci colonization.

Authors:  Hee Kyoung Choi; Kye Hyung Kim; Sun Hee Lee; Su Jin Lee
Journal:  J Korean Med Sci       Date:  2011-06-20       Impact factor: 2.153

6.  Characterization of Clostridium difficile Strains Isolated from Patients with C. difficile-associated Disease in Korea.

Authors:  Seung-Hak Cho; Jung-Whan Chon; Kun-Ho Seo; Young Kwon Kim; Jung-Beom Kim; Young-Seok Bak; Woon-Won Jung; Cheorl-Ho Kim; Jong Tae Choi
Journal:  Osong Public Health Res Perspect       Date:  2017-10-31
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.